Related references
Note: Only part of the references are listed.Renal Compression in Heart Failure The Renal Tamponade Hypothesis
Eva M. Boorsma et al.
JACC-HEART FAILURE (2022)
Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease
Jeroen V. Koomen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial
Jeroen Koomen et al.
DIABETES OBESITY & METABOLISM (2021)
Endothelin-1 rs9296344 associates with the susceptibility of childhood primary nephrotic syndrome
Ruifeng Zhang et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Target-Mediated Population Pharmacokinetic Modeling of Endothelin Receptor Antagonists
Anke-Katrin Volz et al.
PHARMACEUTICAL RESEARCH (2020)
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Hiddo J. L. Heerspink et al.
LANCET (2019)
Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients
W. S. Oetting et al.
PHARMACOGENOMICS JOURNAL (2018)
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy
Hiddo J. L. Heerspink et al.
DIABETES OBESITY & METABOLISM (2018)
Identification of two novel genes SLC15A2 and SLCO1B3 associated with maintenance dose variability of warfarin in a Chinese population
Liang-Liang Cai et al.
SCIENTIFIC REPORTS (2017)
Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1)
Hannah H. Lee et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Comparison of exposure response relationship of atrasentan between North American and Asian populations
Hiddo J. L. Heerspink et al.
DIABETES OBESITY & METABOLISM (2017)
Endothelin
Anthony P. Davenport et al.
PHARMACOLOGICAL REVIEWS (2016)
Polymorphism in Endothelin-1 Gene: An Overview
Musa Ahmed et al.
CURRENT CLINICAL PHARMACOLOGY (2016)
Influence of SLCO1B3 Genetic Variations on Tacrolimus Pharmacokinetics in Renal Transplant Recipients
Andree-Anne Bolvin et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Improving the efficacy of RAAS blockade in patients with chronic kidney disease
Hiddo J. Lambers Heerspink et al.
NATURE REVIEWS NEPHROLOGY (2013)
UGT1A1 is a major locus influencing bilirubin levels in African Americans
Guanjie Chen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
Laura B. Ramsey et al.
GENOME RESEARCH (2012)
Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro
Johanna Weiss et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Pharmacokinetic Impact of SLCO1A2 Polymorphisms on Imatinib Disposition in Patients With Chronic Myeloid Leukemia
Y. Yamakawa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
Qiang Ma et al.
PHARMACOLOGICAL REVIEWS (2011)
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Mikko Niemi et al.
PHARMACOLOGICAL REVIEWS (2011)
Genome-wide association of serum bilirubin levels in Korean population
Tae-Wook Kang et al.
HUMAN MOLECULAR GENETICS (2010)
Avosentan for Overt Diabetic Nephropathy
Johannes F. E. Mann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Genetic Polymorphisms in CYP3A5 and MDR1 Genes and Their Correlations With Plasma Levels of Tacrolimus and Cyclosporine in Renal Transplant Recipients
J. Mendes et al.
TRANSPLANTATION PROCEEDINGS (2009)
Global analysis of genetic variation in SLCOIB1
Marja K. Pasanen et al.
PHARMACOGENOMICS (2008)
Role of OATP transporters in the disposition of drugs
Mikko Niemi
PHARMACOGENOMICS (2007)
Dual effects of rifampin on the pharmacokinetics of atrasentan
Hao Xiong et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
Marja K. Pasanen et al.
PHARMACOGENETICS AND GENOMICS (2006)
Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics
DA Katz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Share Paper
